AC
ZLAB icon

AXQ Capital’s Zai Lab ZLAB Stock Holding History

AXQ Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,694
Closed -$201K – 1408
2026
Q1 		$201K Buy
+10,694
New +$198K 0.03% 746

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AXQ Capital's ZLAB Position: Q2 2026 in Review

AXQ Capital sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 10,694 shares — an estimated $201K sold.

AXQ Capital first reported a position in ZLAB in Q1 2026 and held it in 1 quarter. The position peaked at $201K in Q1 2026. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • AXQ Capital reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 10,694 Zai Lab shares in Q2 2026, an estimated $201K.
  • AXQ Capital first reported a position in Zai Lab in Q1 2026 and held it in 1 quarter.
  • AXQ Capital's Zai Lab position peaked at $201K in Q1 2026.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.